Molecular investigation of the viral kinetics of equine herpesvirus-1 in blood and nasal secretions of horses after corticosteroid-induced recrudescence of latent infection

Journal of Veterinary Internal Medicine

Volumn 24, Issue 5, 2010, Pages 1153-1157

  Pusterla, N ^a   Hussey, S B ^b   Mapes, S ^a   Johnson, C ^a   Collier, J R ^a   Hill, J ^a   Lunn, D P ^b   Wilson, W D ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Veterinary Dentistry and Oral Surgery   (United States)

Author keywords

EHV 1; Reactivation; Transmission

Indexed keywords

CORTICOSTEROID; DEXAMETHASONE;

ANIMAL; ARTICLE; BLOOD; DRUG EFFECT; EQUINE HERPES VIRUS; HORSE; HORSE DISEASE; IMMUNOLOGY; MALE; MUCUS; PHYSIOLOGY; TIME; VIROLOGY; VIRUS LATENCY; VIRUS REPLICATION;

ADRENAL CORTEX HORMONES; ANIMALS; DEXAMETHASONE; HERPESVIRUS 1, EQUID; HORSE DISEASES; HORSES; MALE; MUCUS; TIME FACTORS; VIRUS LATENCY; VIRUS REPLICATION;

ANIMALIA; EQUID HERPESVIRUS 1; EQUIDAE;

EID: 77957893013     PISSN: 08916640     EISSN: 19391676     Source Type: Journal    
DOI: 10.1111/j.1939-1676.2010.0554.x     Document Type: Article

References (15)

1. Slater J. Equine herpesviruses. In: Sellon DC, Long MT, eds. Equine Infectious Diseases. St Louis, MO: Saunders Elsevier; 2007:134-153.
2. Allen GP, Bolin DC, Bryant U, et al. Prevalence of latent, neuropathogenic equine herpesvirus-1 in the Thoroughbred broodmare population of central Kentucky. Equine Vet J 2008;40: 105-110.
3. Edington N, Bridges CG, Huckle A. Experimental reactivation of equid herpesvirus 1 (EHV 1) following the administration of corticosteroids. Equine Vet J 1985;17:369-372.
4. Gibson JS, Slater JD, Awan AR, et al. Pathogenesis of equine herpesvirus-1 in specific pathogen-free foals: Primary and secondary infections and reactivation. Arch Virol 1992;123:351-366.
5. Gibons JS, O'Neil TO, Thackray A, et al. Serological responses of specific pathogen-free foals to equine herpesvirus-1: Primary and secondary infection, and reactivation. Vet Microbiol 1992;32:199-214.
6. Slater JD, Borchers K, Thackray AM, et al. The trigeminal ganglion is a location for equine herpesvirus 1 latency and reactivation in horses. J Gen Virol 1994;75:2007-2016.
7. Pusterla N, Hussey SB, Mapes S, et al. Comparison of four methods to quantify equid herpesvirus 1 load by real-time polymerase chain reaction in nasal secretions of experimentally and naturally infected horses. J Vet Diagn Invest 2009;21:836-840.
8. Pusterla N, Wilson WD, Mapes S, et al. Characterization of viral loads, strain and state of equine herpesvirus-1 using real-time PCR in horses following natural exposure at a racetrack in California. Vet J 2009;179:230-239.
9. Crabb BS, MacPherson CM, Reubel GH, et al. A typespecific serological test to distinguish antibodies to equine herpesviruses 4 and 1. Arch Virol 1995;140:245-258.
10. Drummer HE, Reynolds A, Studdert M, et al. Application of an equine herpesvirus 1 (EHV1) type-specific ELISA to the management of an outbreak of EHV1 abortion. Vet Rec 1995;36:579-581.
11. Gilkerson JR, Whalley JM, Drummer HE, et al. Epidemiological studies of equine herpesvirus 1 (EHV-1) in Thoroughbred foals: A review of studies conducted in the Hunter Valley of New South Wales between 1995 and 1997. Vet Microbiol 1999;68:15-25.
12. Allen GP. Risk factors for development of neurologic disease after experimental exposure to equine herpesvirus-1 in horses. Am J Vet Res 2008;69:1595-1600.
13. Pusterla N, Leutenegger CM, Wilson WD, et al. Equine herpesvirus-4 kinetics in peripheral blood leukocytes and nasopharyngeal secretions in foals using quantitative real-time Taq Man PCR. J Vet Diagn Invest 2005;17:578-581.
14. Perkins GA, Goodman LB, Dubovi EJ, et al. Detection of equine herpesvirus-1 in nasal swabs of horses by quantitative real time PCR. J Vet Intern Med 2008;22:1234-1238.
15. Pusterla N, Mapes S. Detection and characterization of equine herpesvirus-1 strains in submandibular lymph nodes and trigeminal ganglia from horses using real-time PCR. Proceedings, Annual ACVIM Forum, San Antonio, TX, 2008: 818.